🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Standard BioTools Inc.

LAB Healthcare
$0.669 +$0.02 (3.51%)
Market Cap: $262.64 M
Gurus Holding
6
Popularity Rank
#1521
% of Shares Held
16.88%
Net Activity (Q2 2026)
+$2.98 M

Guru Ownership Trend

Guru Analysis for Standard BioTools Inc. (LAB)

Standard BioTools Inc. (LAB), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q2 2026, a total of 6 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $44.32 M.

Top institutional holders include Andreas Halvorsen and Chuck Royce.

Institutional sentiment is currently Bullish. This is evidenced by a $2.98 M net inflow during the quarter.

Recent activity highlights Steven Cohen who dramatically increased their stake.

Key Holders

Top 5 by Value

Recent Activity Breakdown (Q2 2026)

+$2.98 M
Total Buy Value
New Buys 2
Additions 3
-$0
Total Sell Value
Reductions 0
Sold Out 0

Guru Consensus (Q2 2026)

Based on recent activity
Net Sellers
0
Net Buyers
5

FAQs for Standard BioTools Inc. (LAB)

Major holders include Andreas Halvorsen ($48.25 M), Chuck Royce ($3.72 M), Cliff Asness ($1.12 M). According to the latest reported data, 6 tracked investment managers collectively hold approximately 66.25 M shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $2.98 M, with 5 managers increasing positions and 0 managers reducing holdings.

No tracked managers reduced or fully exited their positions in LAB during the most recent reporting period.

Yes, 2 managers opened new positions in LAB, and 3 increased their existing holdings. The total reported buy value was $2.98 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.14% 58,651,170 $48.25 M Q2 2026
0.03% Add 50.6% 4,525,333 $3.72 M Q2 2026
0.00% Add 45.7% 1,359,018 $1.12 M Q2 2026
0.00% New Buy 992,058 $816,166 Q2 2026
0.00% Add 1483.1% 707,991 $582,464 Q2 2026
0.00% New Buy 17,675 $14,541 Q2 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form